CN Patent

CN101058561B — 用于抑制蛋白激酶的二苯脲衍生物及其组合物和用途

Assigned to ASCEPION PHARMACEUTICALS Inc · Expires 2011-01-26 · 15y expired

What this patent protects

本发明提供了具有下式(I)的化合物或其药学上可接受的盐、溶剂合物或前体药。本发明的化合物能显著地抑制VEGFR2和/或PDGFRβ的生物活性。 式(I)

USPTO Abstract

本发明提供了具有下式(I)的化合物或其药学上可接受的盐、溶剂合物或前体药。本发明的化合物能显著地抑制VEGFR2和/或PDGFRβ的生物活性。 式(I)

Drugs covered by this patent

Patent Metadata

Patent number
CN101058561B
Jurisdiction
CN
Classification
—
Expires
2011-01-26
Drug substance claim
No
Drug product claim
No
Assignee
ASCEPION PHARMACEUTICALS Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.